WOOJUNG BIO Statistics

Total Valuation

WOOJUNG BIO has a market cap or net worth of KRW 36.02 billion. The enterprise value is 85.24 billion.

Market Cap	36.02B
Enterprise Value	85.24B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

WOOJUNG BIO has 16.83 million shares outstanding. The number of shares has increased by 16.72% in one year.

Current Share Class	16.83M
Shares Outstanding	16.83M
Shares Change (YoY)	+16.72%
Shares Change (QoQ)	-10.77%
Owned by Insiders (%)	33.61%
Owned by Institutions (%)	3.65%
Float	10.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.97
PB Ratio	1.47
P/TBV Ratio	1.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 85.65, with an EV/FCF ratio of -19.46.

EV / Earnings	-22.90
EV / Sales	2.30
EV / EBITDA	85.65
EV / EBIT	n/a
EV / FCF	-19.46

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 2.10.

Current Ratio	0.56
Quick Ratio	0.19
Debt / Equity	2.10
Debt / EBITDA	51.76
Debt / FCF	-11.80
Interest Coverage	-0.97

Financial Efficiency

Return on equity (ROE) is -14.49% and return on invested capital (ROIC) is -2.36%.

Return on Equity (ROE)	-14.49%
Return on Assets (ROA)	-2.02%
Return on Invested Capital (ROIC)	-2.36%
Return on Capital Employed (ROCE)	-4.95%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.42
Inventory Turnover	4.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.35% in the last 52 weeks. The beta is 0.42, so WOOJUNG BIO's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	+28.35%
50-Day Moving Average	1,944.72
200-Day Moving Average	1,725.20
Relative Strength Index (RSI)	54.27
Average Volume (20 Days)	410,807

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WOOJUNG BIO had revenue of KRW 37.12 billion and -3.72 billion in losses. Loss per share was -267.16.

Revenue	37.12B
Gross Profit	10.61B
Operating Income	-2.88B
Pretax Income	-3.72B
Net Income	-3.72B
EBITDA	998.41M
EBIT	-2.88B
Loss Per Share	-267.16

Full Income Statement

Balance Sheet

The company has 2.45 billion in cash and 51.68 billion in debt, giving a net cash position of -49.23 billion or -2,925.09 per share.

Cash & Cash Equivalents	2.45B
Total Debt	51.68B
Net Cash	-49.23B
Net Cash Per Share	-2,925.09
Equity (Book Value)	24.58B
Book Value Per Share	1,476.09
Working Capital	-13.85B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.05 billion and capital expenditures -333.44 million, giving a free cash flow of -4.38 billion.

Operating Cash Flow	-4.05B
Capital Expenditures	-333.44M
Free Cash Flow	-4.38B
FCF Per Share	-260.28

Full Cash Flow Statement

Margins

Gross margin is 28.57%, with operating and profit margins of -7.75% and -10.03%.

Gross Margin	28.57%
Operating Margin	-7.75%
Pretax Margin	-10.03%
Profit Margin	-10.03%
EBITDA Margin	2.69%
EBIT Margin	-7.75%
FCF Margin	n/a

Dividends & Yields

WOOJUNG BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.72%
Shareholder Yield	-16.72%
Earnings Yield	-10.34%
FCF Yield	-12.16%

Stock Splits

The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jul 30, 2019
Split Type	Forward
Split Ratio	2

Scores

WOOJUNG BIO has an Altman Z-Score of -0.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.08
Piotroski F-Score	2